Loading...
XNAS
SNCE
Mar 11, Last price  
5.75USD
Name

Science 37 Holdings Inc

Chart & Performance

D1W1MN
XNAS:SNCE chart
P/E
P/S
0.49
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
70m
+17.70%
023,704,00059,597,00070,147,000
Net income
-51m
L-45.95%
-1,000-32,369,000-94,331,000-50,988,000
CFO
-75m
L+106.82%
0-25,476,000-36,478,000-75,443,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches. Its platform enables modern and digital approaches to clinical research by bringing together all parties, including the patient and trial investigators, nurses, coordinators, and sponsors to power workflows, centralize evidence generation, and harmonize data. Its platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating agile clinical trials; and extensive configuration to support virtually any phase of clinical study and any indication. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.
IPO date
Nov 20, 2020
Employees
460
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFY
2022‑122021‑122021‑062020‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT